DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
AD1029143
Title:
Novel Approaches to Breast Cancer Prevention and Inhibition of Metastases
Descriptive Note:
Technical Report,30 Sep 2015,29 Sep 2016
Corporate Author:
IMBA Institut fuer Molekulare Biotechnologie GmbH Vienna Austria
Report Date:
2016-10-01
Pagination or Media Count:
39.0
Abstract:
Technologies such as transcriptional profiling, genome sequencing, epigenetic, proteomic or metabolomic profiling have resulted in large sets of genome wide data. However, most of these datasets are of correlative. Functional and phenotypic annotation of the genome is thus a key challenge for a fundamental understanding of physiology and disease pathogenesis. We combine genetic model organisms and repairable mutagenesis with in vivo mouse genetics and human cohort studies to functionally characterize candidate breast cancer genes. Using mouse genetics, we showed that RANKL and its receptor RANK are critical regulators of sex hormone and BRCA1 mutation-driven breast cancer, providing a rationale for cancer prevention trials.
Distribution Statement:
APPROVED FOR PUBLIC RELEASE